drugset / Trial / NCT00494481
E3 Breast Cancer Taxotere Combination
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the efficacy of ZD6474 in combination with docetaxel in the treatment of ABC using the progression event count methodology
Timeline
- Start
- 2006-01
- Primary completion
- 2007-06
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vandetanib | Small molecule | — | Oral |
| Background | Docetaxel | Small molecule | — | Intravenous |